van der Veen F. Sieve-Smith L. Insulin-sensitizing agents, oral contraceptives, spironolactone, and topical eflornithine can be used in patients with hirsutism. There was an excellent clinical response in 19 (61%), incomplete response in 8 (26%), no response in 5 women. Wells GA, Bridger T, Tracy T, Department of Health and Human Services: "Polycystic Ovary Syndrome," "Glossary. Luna S, The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome. Dodin S, Polycystic ovary syndrome (PCOS) is not a simple pathophysiologic process for which one treatment addresses all manifestations. Parsanezhad MD, McLaughlin TL, Multiple pregnancy/ovarian hyperstimulation, thromboembolism, visual disturbances$52 (generic) and $128 (brand) for 100 mg per day for 5 daysHirsutism; infertility; insulin resistance; menstrual irregularitiesGI upset, lactic acidosis, increase in homocysteine levels$73 (generic) and $107 (brand) for 850 mg twice per dayNausea, headache, spotting, thrombophlebitis, deep venous thrombosisHirsutism; infertility; insulin resistance; menstrual irregularitiesCHF, hepatotoxicity, edema, increase in homocysteine levels2 to 8 mg per day (beneficial effects are dose related)$61 (generic) and $97 (brand) for 50 mg twice per dayIncreased total cholesterol and low-density lipoprotein cholesterol; thromboembolism, stroke, MI0.15 mg desogestrel plus 30 mcg ethinyl estradiol per dayNonsteroidal antiandrogen used mostly in prostate cancerThrombocytopenia, leukopenia, liver toxicity, hot flashesNonsteroidal competitive inhibitor of aromatase; inhibits conversion of adrenal androgensOsteoporosis, thromboembolism, MI, hot flashes, arthralgiasMultiple pregnancy/ovarian hyperstimulation, thromboembolism, visual disturbances$52 (generic) and $128 (brand) for 100 mg per day for 5 daysHirsutism; infertility; insulin resistance; menstrual irregularitiesGI upset, lactic acidosis, increase in homocysteine levels$73 (generic) and $107 (brand) for 850 mg twice per dayNausea, headache, spotting, thrombophlebitis, deep venous thrombosisHirsutism; infertility; insulin resistance; menstrual irregularitiesCHF, hepatotoxicity, edema, increase in homocysteine levels2 to 8 mg per day (beneficial effects are dose related)$61 (generic) and $97 (brand) for 50 mg twice per dayIncreased total cholesterol and low-density lipoprotein cholesterol; thromboembolism, stroke, MI0.15 mg desogestrel plus 30 mcg ethinyl estradiol per dayNonsteroidal antiandrogen used mostly in prostate cancerThrombocytopenia, leukopenia, liver toxicity, hot flashesNonsteroidal competitive inhibitor of aromatase; inhibits conversion of adrenal androgensOsteoporosis, thromboembolism, MI, hot flashes, arthralgiasTreatments for hirsutism in women with PCOS are similar to those in women without PCOS, such as patients with idiopathic hirsutism. Barnhart HX, Kruger TF, Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome.
It isn't recommended if you're pregnant or planning to become pregnant. Acarbose in obese patients with polycystic ovarian syndrome: a double-blind, randomized, placebo-controlled study. Norman JE, Cyproterone acetate plus ethinyl estradiol has been extensively studied, but it is not available in the United States. Steyn DW, Department of Health and Human Services: "Polycystic Ovary Syndrome," "Glossary.

Törüner FB, McCormick C, This use of birth control pills also protects against abnormal growth of the lining of the uterus. Nosarka S. Never ignore professional medical advice in seeking treatment because of something you have read on the WebMD Site. LEE RADOSH, MD, The Reading Hospital and Medical Center, Reading, PennsylvaniaPolycystic ovary syndrome is a condition present in approximately 5 to 10 percent of women of childbearing age. Lemay A, Insulin-sensitizing agents, oral contraceptives, spironolactone, and topical eflornithine can be used in patients with hirsutism. Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin. Six of 18 patients with sterility became pregnant during … Rosenwaks Z. 2005 Sep;39(9):1517-21. doi: 10.1345/aph.1G025.
Bugari G. Flight IH, Vafaei H, The clinical features may include hyperandrogenism (with the clinical manifestations of oligomenorrhoea, hirsutism, and acne), ovulation disorders, and polycystic ovarian morphology. Metformin in polycystic ovary syndrome: systematic review and meta-analysis. Lord JM,